Related Experiment Video
Updated: Jul 7, 2025

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
Published on: September 23, 2021
Immunogenic Cell Stress and Death Sensitize Tumors to Immunotherapy
Oliver Kepp1,2, Guido Kroemer1,2,3
1Centre de Recherche des Cordeliers, Equipe Labellisée par la Ligue Contre le Cancer, Université de Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, 75006 Paris, France.
Abstract:
The efficacy of chemotherapy with cytotoxicants and that of targeted therapies with more sophisticated agents is limited due to the plasticity of malignant cells, which leads to the inevitable development of resistance [...].
Insights
Malignant cell plasticity drives resistance to chemotherapy and targeted therapies, limiting treatment effectiveness. Understanding this adaptability is key to overcoming therapeutic challenges in cancer.
Area of Science:
- Oncology
- Cancer Biology
- Pharmacology
Background:
- Chemotherapy and targeted therapies are mainstays of cancer treatment.
- Malignant cell plasticity is a significant challenge, leading to treatment resistance.
- Developing resistance limits the long-term efficacy of current cancer interventions.
Related Concept Videos
Tumor Immunotherapy
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Psychoneuroimmunology: Diabetes and Cancer
The Tumor Microenvironment
Cell-mediated Immune Responses
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

